Intelligent Bio Solutions Inc
(INBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 1,181 | 457 | 357 | 0 | 0 |
| Cost of Goods | 394 | 424 | 113 | N/A | N/A |
| Gross Profit | 787 | 33 | 244 | N/A | N/A |
| Operating Expenses | 3,883 | 7,001 | 2,488 | 1,218 | 2,088 |
| Operating Income | -2,703 | -6,543 | -2,131 | -1,218 | -2,088 |
| Interest Expense | 60 | 86 | 77 | 1 | 3 |
| Other Income | 91 | 278 | 1,781 | 5 | 3 |
| Pre-tax Income | -2,671 | -6,352 | -427 | -1,214 | -2,088 |
| Net Income Continuous | -2,671 | -6,352 | -427 | -1,214 | -2,088 |
| Minority Interests | -13 | -8 | -7 | -6 | -10 |
| Net Income | $-2,659 | $-6,344 | $-421 | $-1,208 | $-2,078 |
| EPS Basic Total Ops | -333.22 | -686.70 | -55.60 | -194.48 | -346.94 |
| EPS Basic Continuous Ops | -334.03 | -687.53 | -56.42 | -195.90 | -343.03 |
| EPS Diluted Total Ops | -333.22 | -686.70 | -55.60 | -194.48 | -346.94 |
| EPS Diluted Continuous Ops | -334.03 | -687.53 | -56.42 | -195.90 | -343.03 |
| EBITDA(a) | $-2,623 | $-2,000 | $-2,131 | $-1,218 | $-2,088 |